Urinary Stents or Ureteral Stents Market Report 2026

The urinary stents or ureteral stents market size has grown strongly in recent years. It will grow from $0.51 billion in 2025 to $0.54 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing incidence of kidney stone cases, rising number of urological surgeries, improved imaging and placement techniques, wider acceptance of ureteral stents, expansion of hospital-based urology departments.

The urinary stents or ureteral stents market size is expected to see strong growth in the next few years. It will grow to $0.69 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing demand for next-generation stent materials, rising focus on infection-resistant designs, expansion of outpatient urological procedures, increasing adoption of precision-guided stent placement, advancements in bioresorbable stent technology. Major trends in the forecast period include increasing adoption of biodegradable stent materials, rising demand for long-term ureteral drainage solutions, growing use of minimally invasive urological procedures, expansion of customized stent designs, enhanced focus on patient comfort and safety.

The rising incidence of kidney diseases is expected to drive the growth of the urinary stents or ureteral stents market going forward. Kidney diseases include conditions such as chronic kidney disease (CKD), kidney stones, urinary tract obstructions, and infections that compromise the structure and function of the kidneys. The increasing prevalence of diabetes and hypertension, which are major metabolic contributors to kidney damage, is fueling this rise. The urinary stents or ureteral stents market supports this trend by helping maintain urine flow, preventing blockages, and protecting kidney function in patients with CKD, stones, or other obstructive conditions. For example, in June 2023, Kidney Research UK, a UK-based charitable organization dedicated to kidney research and advocacy, reported that approximately 7.19 million people in the UK were affected by chronic kidney disease in 2023 - over 10% of the population - with projections reaching 7.61 million by 2033. Therefore, the growing incidence of kidney diseases is boosting the urinary stents or ureteral stents market.

Key companies in the urinary stents or ureteral stents market are focusing on developing innovative solutions, such as drug-eluting stents, to reduce infections, prevent encrustation, and improve patient outcomes. A drug-eluting stent is a medical device designed to gradually release medication to prevent complications such as infection, inflammation, or tissue blockage. For instance, in January 2025, University Hospitals (UH), a US-based nonprofit academic medical center, announced that the FDA granted 510(k) clearance for the RELIEF ureteral stent to prevent vesicoureteral reflux. The RELIEF stent features a suture‑tethered, floating bladder coil that enables natural opening and closing of the ureteral orifice, reducing urine backflow and minimizing bladder irritation. Clinical studies showed that the stent effectively prevents reflux while improving patient comfort compared with traditional ureteral stents. UH plans to incorporate the RELIEF stent into its urology practice to enhance treatment outcomes for patients with vesicoureteral reflux.

In February 2023, Olympus Corporation, a Japan-based manufacturer of optical and digital precision technology, acquired Taewoong Medical Co. Ltd. for approximately $370 million. Through this acquisition, Olympus aims to strengthen its gastrointestinal device portfolio and expand its capabilities in minimally invasive treatments by integrating Taewoong Medical's advanced stent technologies. Taewoong Medical Co. Ltd., based in Korea, specializes in the manufacture of gastrointestinal metallic stents and ureteral stents.

Major companies operating in the urinary stents or ureteral stents market are Boston Scientific Corporation, Coloplast A/S, Teleflex Incorporated, Cook Medical LLC, Merit Medical Systems Inc., Lepu Medical Technology Co. Ltd., Applied Medical Resources Corporation, Well Lead Medical Co. Ltd., Micro‑Tech Nanjing Co. Ltd., Medi‑Globe GmbH, Pnn Medical A/S, Rocamed SAM, HydrUStent SA, Urovision GmbH, MED PRO MEDICAL B.V., Medtronic plc, B Braun Melsungen AG, Allium Medical Solutions Ltd, Richard Wolf GmbH, KARL STORZ SE & Co. KG.

North America was the largest region in the urinary stents or ureteral stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary stents or ureteral stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urinary stents or ureteral stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the urinary stents market by increasing costs of imported polymers, specialty metals, coatings, and precision manufacturing equipment used in stent production. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported medical devices, while Asia-Pacific faces pricing pressure on export-oriented stent manufacturing. These tariffs are raising device procurement costs and influencing purchasing decisions. However, they are also supporting domestic stent manufacturing, regional material sourcing, and innovation in cost-efficient ureteral stent designs.

The urinary stents or ureteral stents market research report is one of a series of new reports that provides urinary stents or ureteral stents market statistics, including urinary stents or ureteral stents industry global market size, regional shares, competitors with a urinary stents or ureteral stents market share, detailed urinary stents or ureteral stents market segments, market trends and opportunities, and any further data you may need to thrive in the urinary stents or ureteral stents industry. This urinary stents or ureteral stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Urinary stents, also referred to as ureteral stents, are medical devices placed in the ureters - the tubes that transport urine from the kidneys to the bladder - to maintain or restore proper urine flow. They are commonly used in cases of blockage, injury, or narrowing of the ureter, which may result from kidney stones, tumors, or surgical procedures. These stents help prevent urine backflow, reduce the risk of kidney damage, and alleviate symptoms such as pain or infection.

The primary types of urinary or ureteral stents include open-end stents, closed-end stents, double pigtail stents, and multiloop stents. Open-end stents are tubular devices designed to keep passages open, allowing unobstructed urine flow in blocked ureters. Ureteral stents are manufactured from materials such as metals, polymers, and biodegradable hydrogel. They are utilized for various medical applications, including the treatment of kidney stones, kidney failure, urinary tract infections, urinary incontinence, and other conditions. These stents are employed by different end users, including hospitals and specialty centers, ambulatory surgical centers, and academic and research institutions.

The urinary stents or ureteral stents market consists of sales of double-J stents, non-coated stents, metallic stents, and percutaneous nephrostomy stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.